KPT-276 – 5 mg

Brand:
Cayman
CAS:
1421919-75-6
Storage:
-20
UN-No:
Non-Hazardous - /

KPT-276 is an orally bioavailable inhibitor of Exportin 1 (XPO1/CRM1) with anticancer activity.{47263} In vivo, KPT-276 (150 mg/kg) increases survival and reduces spleen weight and white blood cell count in an MV4-11 acute myeloid leukemia (AML) mouse xenograft model. It also reduces tumor volume and increases survival in a BT 145 glioblastoma mouse xenograft model when administered at a dose of 75 mg/kg.{53291}  

 

Available on backorder

SKU: 29158 - 5 mg Category:

Description

An inhibitor of XPO1/CRM1; increases survival and reduces spleen weight and white blood cell count in an MV4-11 AML mouse xenograft model at 150 mg/kg; reduces tumor volume and increases survival in a BT 145 glioblastoma mouse xenograft model at 75 mg/kg


Formal name: (2Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-1-(3,3-difluoro-1-azetidinyl)-2-propen-1-one

Synonyms: 

Molecular weight: 426.3

CAS: 1421919-75-6

Purity: ≥98%

Formulation: A solid